Prescription Drug News and Research

RSS

Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

29 Aug 2023

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

America's pharmaceutical giants are suing this summer to block the federal government's first effort at drug price regulation.

18 Aug 2023

Seeking Medicare coverage for weight loss drugs, pharma giant courts Black influencers

Pharmaceutical giant Novo Nordisk has turned to influential Black Americans in pursuit of what would be a lucrative victory: having Medicare cover a new class of weight loss drugs, including the company's highly sought Wegovy, which can cost patients more than $1,000 a month.

8 Aug 2023

Survey: Americans want weight loss drugs despite high cost

Many Americans really want to lose weight — and a new poll shows nearly half of adults would be interested in taking a prescription drug to help them do so.

5 Aug 2023

KFF Health News' 'What the Health?': Another try for mental health ‘parity’

The Biden administration continued a bipartisan, decades-long effort to ensure that health insurance treats mental illnesses the same as other ailments, with a new set of regulations aimed at ensuring that services are actually available without years-long waits or excessive out-of-pocket costs.

27 Jul 2023

Muscle-building supplement may help protect memory and prevent Alzheimer's disease

The secret to protecting your memory may be a staple of a bodybuilder's diet. RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the progression of Alzheimer's disease.

21 Jul 2023

Wait, What’s a PBM?

Pharmacy benefit managers, or PBMs, are intermediary companies that negotiate the price of prescription drugs.

13 Jul 2023

THC-O-acetate's psychedelic effects may be greatly exaggerated

The cannabis plant is complex, with about 100 cannabinoids, or compounds, many of which science still knows little or nothing about.

11 Jul 2023

The American Journal of Health Economics articles examine policies to address opioid crisis

The August 2023 issue of the American Journal of Health Economics will feature a cluster of articles that examine the opioid crisis.

10 Jul 2023

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it's not always clear who's sponsoring the ads or why.

10 Jul 2023

Medical cannabis laws have no effect on opioid prescriptions, study finds

State laws allowing medical cannabis use did not reduce prescriptions for opioids or other therapies for chronic, non-cancer pain, according to a policy analysis by Weill Cornell Medicine investigators.

5 Jul 2023

Food for thought: South European Atlantic diet shows promising link to lower depression risk

Researchers evaluate the effects of the Southern European Atlantic Diet on depression.

27 Jun 2023

Opioid overdose deaths may be reduced by increasing access to prescription opioid painkillers

Increasing access to prescription opioid painkillers may reduce opioid overdose deaths in the United States, according to a Rutgers study.

27 Jun 2023

Closed Loop Medicine appoints Kate Woolland as Chief Operating Officer

The key executive appointment supports the strategic, operational delivery of the Company’s product and partnership programs.

From Closed Loop Medicine 20 Jun 2023

Mark Cuban's Cost Plus Drug Company projects huge savings over Medicare for generic cancer medications

Researchers reveal significant cost savings when generic oncology drugs are purchased through the Mark Cuban Cost Plus Drug Company.

13 Jun 2023

Study reveals elevated risk of ischemic stroke in women and men with migraine headaches

Women and men who experience migraine headaches also carry an elevated risk of having an ischemic stroke, but women alone may carry an additional risk of heart attack and hemorrhagic stroke, according to a new study led by Cecilia Hvitfeldt Fuglsang of Aarhus University, Denmark publishing June 13th in the open access journal PLOS Medicine.

13 Jun 2023

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called "orphan" drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration review.

12 Jun 2023

Study analyzes the effects of state-level policies on use of anti-opioid medication

States that want to increase access to buprenorphine, a lifesaving medication used to treat opioid use disorder, should consider efforts to enhance professional education and clinician knowledge, according to a new RAND Corporation study.

26 May 2023

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin.

25 May 2023

Are US prescription drug prices 10 times those of other nations? Only sometimes

Sen. Bernie Sanders (I-Vt.), whether in Congress or as a presidential candidate, has always taken strong positions against the high cost of prescription drugs.

19 May 2023